Statins shown to cause, not prevent, breast cancer

As we’ve told you over the years, it looks like Big Pharma and its minions will stop at nothing until every man, woman, and child is popping statin drugs such as Lipitor, Crestor, and Zocor.

This, however, could be the cheapest, most low-down trick of all.

A group of pharma-connected researchers are trying to tell us that taking a statin can help save your life, should you be diagnosed with breast cancer.

Not only that, but healthy women need to start up on a statin ASAP, they say, as those “regular users” will have even more benefits should they come down with cancer.

But anyone, doctors included, who take those findings at face value need to know this: Numerous previous studies have found the exact opposite effect, especially where seniors are concerned.

In fact, the evidence has been piling up that statin drugs are much more likely to cause cancer than to ever prevent it.

Smoke and mirrors
Cataracts, diabetes, Parkinson’s disease, devastating muscle pain — how much more bad news do we need to hear about statin drugs before saying “enough?!”

Well, how about the Big C?

It should be no secret to any doctor who has followed statin research that these drugs have long been linked to a variety of cancers.

Four years ago, for example, researchers from the Fred Hutchinson Cancer Research Center in Seattle discovered that women taking statins for a decade or more had a two-and-a-half times higher risk of developing breast cancer.

And almost 10 years ago, physicians from the U.S. and Italy told how the data showed that “statins actually increase cancer in certain segments of the population” — with seniors being particularly at risk.

That cancer link goes all the way back to a statin trial done during the 1990s called CARE (funded by Bristol-Myers Squibb), which found “an alarming increase” in breast cancers (some of which were recurrences) in the women who participated.

And you won’t believe what happened after that! Did the researchers immediately notify doctors and patients… or start a new study to closely examine how breast cancer and statins might be connected?

None of the above.

Instead, from that time on, anyone who had any kind of cancer was automatically ineligible to participate in a statin drug trial.

How’s that for solving the problem?

But, of course, that didn’t make the statin/cancer link go away. Actually, statins have been found to cause cancer in laboratory animals in doses similar to those people are taking. So those CARE trial findings shouldn’t have been a surprise.

Now, however, a group of researchers out of Denmark (with connections to drugmakers such as Pfizer, Novartis, and AstraZenica) are attempting to make the case that women popping a daily statin drug can up their odds of surviving breast cancer.

The group pulled that rabbit out of a hat by using a statistical magic trick called “relative risk.”

That works by taking a pool of people and estimating how many of them should get a particular condition. Say, for example, they expect two patients to develop a disease — and only one does — they’ll claim that the risk was lowered by 50 percent!

It’s a smoke-and-mirrors deception that Big Pharma uses all the time, but it still won’t stop doctors from telling patients that breast cancer survival is another statin “benefit.” This is why it’s so important that you know the full story.

And statins aren’t just dangerous for women. Last month, I told you about a cardiologist who bravely came forward to tell his peers that the knee-jerk policy in hospitals all across American to prescribe a high-dose statin immediately to any patient who has suffered a stroke has no data to back it up!

It’s all risk… with no known gain.

So, if you’re currently taking any cholesterol-lowering drugs, you need to sit down with your doctor and discuss quitting them as soon as possible.

Because the more we find out about statins, the clearer it becomes how horribly dangerous they really are.

“Statins may up breast cancer – specific and overall survival” Pam Harrison, December 8, 2017, Medscape, medscape.com